Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Radiotracers for Imaging of Fibrosis: Advances during the Last Two Decades and Future DirectionsOlof Eriksson, Irina Velikyan
Bioconjugate Chemistry|May 21, 2009
68Ga-labeling of biotin analogues and their characterizationElisabeth Blom, Bengt Långström, Irina Velikyan
American Journal of Nuclear Medicine and Molecular Imaging|July 20, 2017
Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical useIrina Velikyan, Ulrika Rosenstrom, Olof Eriksson
Pharmaceuticals (Basel, Switzerland)|March 16, 2017
Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine NeoplasmsMelpomeni Fani, Petra Kolenc Peitl, Irina Velikyan
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2010
A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogueVladimir Tolmachev, Irina Velikyan, Mattias Sandström, et al.
Nuclear Medicine and Biology|February 17, 2012
Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATEIrina Velikyan, Hui Xu, Manoj Nair, et al.
Journal of Neuroendocrinology|May 28, 2021
68 Ga-DOTATOC-PET/MRI and 11 C-5-HTP-PET/MRI are superior to 68 Ga-DOTATOC-PET/CT for neuroendocrine tumour imagingHiba Jawlakh, Irina Velikyan, Staffan Welin, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 26, 2013
Organ biodistribution of Germanium-68 in rat in the presence and absence of [(68)Ga]Ga-DOTA-TOC for the extrapolation to the human organ and whole-body radiation dosimetryIrina Velikyan, Gunnar Antoni, Jens Sörensen, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Improved Radiolytic Stability of a 68Ga-labelled Collagelin Analogue for the Imaging of FibrosisIrina Velikyan, Ulrika Rosenström, Maria Rosestedt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATEEzgi Ilan, Irina Velikyan, Mattias Sandström, et al.
Pageof 10